Literature DB >> 33732230

Peroxisome Proliferator-Activated Receptor-δ Deficiency in Microglia Results in Exacerbated Axonal Injury and Tissue Loss in Experimental Autoimmune Encephalomyelitis.

Ellinore R Doroshenko1, Paulina C Drohomyrecky1, Annette Gower2, Heather Whetstone3, Lindsay S Cahill4, Milan Ganguly5, Shoshana Spring4, Tae Joon Yi1,2, John G Sled4,6, Shannon E Dunn1,2,7.   

Abstract

Peroxisome proliferator-activated receptor (PPAR)-δ is a nuclear receptor that functions to maintain metabolic homeostasis, regulate cell growth, and limit the development of excessive inflammation during immune responses. Previously, we reported that PPAR-δ-deficient mice develop a more severe clinical course of experimental autoimmune encephalomyelitis (EAE); however, it was difficult to delineate the role that microglia played in this disease phenotype since PPAR-δ-deficient mice exhibited a number of immune defects that enhanced CNS inflammation upstream of microglia activation. Here, we specifically investigated the role of PPAR-δ in microglia during EAE by using mice where excision of a floxed Ppard allele was driven by expression of a tamoxifen (TAM)-inducible CX3C chemokine receptor 1 promoter-Cre recombinase transgene (Cx3cr1 CreERT2: Ppard fl/fl). We observed that by 30 days of TAM treatment, Cx3cr1 CreERT2: Ppard fl/fl mice exhibited Cre-mediated deletion primarily in microglia and this was accompanied by efficient knockdown of Ppard expression in these cells. Upon induction of EAE, TAM-treated Cx3cr1 CreERT2: Ppard fl/fl mice presented with an exacerbated course of disease compared to TAM-treated Ppard fl/fl controls. Histopathological and magnetic resonance (MR) studies on the spinal cord and brains of EAE mice revealed increased Iba-1 immunoreactivity, axonal injury and CNS tissue loss in the TAM-treated Cx3cr1 CreERT2: Ppard fl/fl group compared to controls. In early EAE, a time when clinical scores and the infiltration of CD45+ leukocytes was equivalent between Cx3cr1 CreERT2: Ppard fl/fl and Ppard fl/fl mice, Ppard-deficient microglia exhibited a more reactive phenotype as evidenced by a shorter maximum process length and lower expression of genes associated with a homeostatic microglia gene signature. In addition, Ppard-deficient microglia exhibited increased expression of genes associated with reactive oxygen species generation, phagocytosis and lipid clearance, M2-activation, and promotion of inflammation. Our results therefore suggest that PPAR-δ has an important role in microglia in limiting bystander tissue damage during neuroinflammation.
Copyright © 2021 Doroshenko, Drohomyrecky, Gower, Whetstone, Cahill, Ganguly, Spring, Yi, Sled and Dunn.

Entities:  

Keywords:  axon injury; experimental autoimmune encephalomyelitis; microglia; neuroinflammation; peroxisome proliferator-activated receptor

Year:  2021        PMID: 33732230      PMCID: PMC7959796          DOI: 10.3389/fimmu.2021.570425

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  78 in total

1.  PPARδ deficient mice develop elevated Th1/Th17 responses and prolonged experimental autoimmune encephalomyelitis.

Authors:  Saravanan Kanakasabai; Crystal C Walline; Sharmistha Chakraborty; John J Bright
Journal:  Brain Res       Date:  2010-12-28       Impact factor: 3.252

2.  The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system.

Authors:  DeRen Huang; Fu-Dong Shi; Steffen Jung; Gary C Pien; Jintang Wang; Thais P Salazar-Mather; Toby T He; Jennifer T Weaver; Hans-Gustaf Ljunggren; Christine A Biron; Dan R Littman; Richard M Ransohoff
Journal:  FASEB J       Date:  2006-05       Impact factor: 5.191

3.  MRI to Assess Neurological Function.

Authors:  Brian J Nieman; Matthijs C van Eede; Shoshana Spring; Jun Dazai; R Mark Henkelman; Jason P Lerch
Journal:  Curr Protoc Mouse Biol       Date:  2018-05-22

4.  Control of microglial neurotoxicity by the fractalkine receptor.

Authors:  Astrid E Cardona; Erik P Pioro; Margaret E Sasse; Volodymyr Kostenko; Sandra M Cardona; Ineke M Dijkstra; Deren Huang; Grahame Kidd; Stephen Dombrowski; RanJan Dutta; Jar-Chi Lee; Donald N Cook; Steffen Jung; Sergio A Lira; Dan R Littman; Richard M Ransohoff
Journal:  Nat Neurosci       Date:  2006-06-18       Impact factor: 24.884

Review 5.  Multiple Sclerosis.

Authors:  Daniel S Reich; Claudia F Lucchinetti; Peter A Calabresi
Journal:  N Engl J Med       Date:  2018-01-11       Impact factor: 91.245

Review 6.  Link between PI3K/AKT/PTEN Pathway and NOX Proteinin Diseases.

Authors:  Atsuko Nakanishi; Yoko Wada; Yasuko Kitagishi; Satoru Matsuda
Journal:  Aging Dis       Date:  2014-06-01       Impact factor: 6.745

Review 7.  Physiological functions of peroxisome proliferator-activated receptor β.

Authors:  Jaap G Neels; Paul A Grimaldi
Journal:  Physiol Rev       Date:  2014-07       Impact factor: 37.312

8.  Peroxisome Proliferator-Activated Receptor-δ Supports the Metabolic Requirements of Cell Growth in TCRβ-Selected Thymocytes and Peripheral CD4+ T Cells.

Authors:  Fei Linda Zhao; Jeeyoon Jennifer Ahn; Edward L Y Chen; Tae Joon Yi; Natalie H Stickle; David Spaner; Juan Carlos Zúñiga-Pflücker; Shannon E Dunn
Journal:  J Immunol       Date:  2018-09-26       Impact factor: 5.422

Review 9.  Microglial signatures and their role in health and disease.

Authors:  Oleg Butovsky; Howard L Weiner
Journal:  Nat Rev Neurosci       Date:  2018-10       Impact factor: 34.870

10.  Comparison of microglia and infiltrating CD11c⁺ cells as antigen presenting cells for T cell proliferation and cytokine response.

Authors:  Agnieszka Wlodarczyk; Morten Løbner; Oriane Cédile; Trevor Owens
Journal:  J Neuroinflammation       Date:  2014-03-25       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.